Does modified ultrafiltration reduce the systemic inflammatory response to cardiac surgery with cardiopulmonary bypass?
Cardiopulmonary bypass (CPB) is associated with an accumulation of total body water and a systemic inflammatory response syndrome (SIRS), which, in turn, is associated with organ dysfunction and postoperative morbidity. It has been suggested that modified ultrafiltration (MUF) may be capable of reducing SIRS and improving clinical outcome by filtering out the inflammatory mediators generated during CPB. This paper reviews the data regarding the use of MUF in paediatric and adult settings. Specifically, three issues will be considered: 1) Does MUF improve clinical outcome? 2) Does MUF reduce the systemic inflammatory response to cardiac surgery with CPB? 3) Is MUF more effective than conventional ultrafiltration in improving clinical outcome?
Chew
Michelle S
MS
Department of Anaesthesia and Intensive Care, Lund University Hospital, Lund, Sweden. michelle.chew@anest.lu.se
D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D006440:Hemofiltration / Q000379:methods*; D006801:Humans; D018746:Systemic Inflammatory Response Syndrome / Q000517:prevention & control*